We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.42B
AUM Growth
+$1.24B
(+20%)
Cap. Flow
+$985M
Cap. Flow
% of AUM
13.27%
Top 10 Holdings %
Top 10 Hldgs %
10.68%
Holding
3,037
New
854
Increased
791
Reduced
777
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$49.3M |
| 2 |
Intuit
INTU
|
+$48.7M |
| 3 |
Costco
COST
|
+$47.9M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$47.4M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$41M |
| 2 |
Dollar General
DG
|
+$39M |
| 3 |
Biogen
BIIB
|
+$36.8M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$29.8M |
| 5 |
Waste Management
WM
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Consumer Discretionary | 16.12% |
| 3 | Healthcare | 11.21% |
| 4 | Financials | 10.17% |
| 5 | Industrials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
RB Global
RBA
$20.8B
| $212K | ﹤0.01% |
3,572
-7,504
| -68% | -$396K |
|
|
AAT
2052
American Assets Trust
AAT
$1.49B
| $211K | ﹤0.01% |
8,761
-11,990
| -58% | -$311K |
|
2053
CALL
Stanley Black & Decker
SWK
$14.2B
| $211K | ﹤0.01% |
+1,300
| New | +$202K |
|
|
2054
PUT
Stanley Black & Decker
SWK
$14.2B
| $211K | ﹤0.01% |
+1,300
| New | +$202K |
|
2055
Anterix
ATEX
$1.83B
| $210K | ﹤0.01% |
6,433
-11,889
| -65% | -$503K |
|
2056
First Bancorp
FBP
$4.4B
| $210K | ﹤0.01% |
40,262
-28,282
| -41% | -$157K |
|
2057
Franco-Nevada
FNV
$41.4B
| $210K | ﹤0.01% |
+1,508
| New | +$224K |
|
2058
The RMR Group
RMR
$342M
| $210K | ﹤0.01% |
+7,632
| New | +$221K |
|
2059
Star Bulk Carriers
SBLK
$3.14B
| $210K | ﹤0.01% |
+30,420
| New | +$205K |
|
|
KAMN
2060
DELISTED
Kaman Corp
KAMN
| $210K | ﹤0.01% |
5,399
-25,724
| -83% | -$1.11M |
|
2061
Axogen
AXGN
$2.1B
| $209K | ﹤0.01% |
17,955
+7,251
| +68% | +$84.2K |
|
2062
FormFactor
FORM
$8.11B
| $209K | ﹤0.01% |
8,383
-49,802
| -86% | -$1.39M |
|
2063
DigitalBridge
DBRG
$2.94B
| $208K | ﹤0.01% |
+19,072
| New | +$185K |
|
2064
Establishment Labs
ESTA
$2.72B
| $208K | ﹤0.01% |
+11,238
| New | +$200K |
|
2065
Peoples Bancorp
PEBO
$1.45B
| $208K | ﹤0.01% |
+10,884
| New | +$224K |
|
|
NBEV
2066
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
| $208K | ﹤0.01% |
120,446
+48,339
| +67% | +$94K |
|
2067
Granite Construction
GVA
$5.45B
| $207K | ﹤0.01% |
+11,734
| New | +$215K |
|
2068
CALL
IBM
IBM
$202B
| $207K | ﹤0.01% |
+1,778
| New | +$209K |
|
|
2069
PUT
IBM
IBM
$202B
| $207K | ﹤0.01% |
+1,778
| New | +$209K |
|
|
ZYNE
2070
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $207K | ﹤0.01% |
62,645
-82,115
| -57% | -$302K |
|
2071
Stagwell
STGW
$1.84B
| $206K | ﹤0.01% |
128,175
+109,648
| +592% | +$226K |
|
2072
Neuronetics
STIM
$120M
| $206K | ﹤0.01% |
+42,482
| New | +$161K |
|
|
CASA
2073
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $206K | ﹤0.01% |
+51,024
| New | +$239K |
|
|
WPG
2074
DELISTED
Washington Prime Group Inc.
WPG
| $206K | ﹤0.01% |
35,384
-57,883
| -62% | -$370K |
|
2075
Banc of California
BANC
$3.28B
| $205K | ﹤0.01% |
20,300
-34,989
| -63% | -$378K |
|
Similar funds
Squarepoint's Q3 2020 Portfolio in Review
As of Q3 2020, Squarepoint held 3,037 positions worth $7.42B, up 20% from $6.18B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $985M of net new capital in Q3 2020, opening 854 new positions and adding to 791 existing holdings. Its largest new stake was Salesforce: 186,017 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $41M trimmed.
- Squarepoint's largest Q3 2020 buy was Salesforce: 186,017 shares worth $46.8M.
- Squarepoint added most to Visa in Q3 2020, an estimated $49.3M increase.
- Squarepoint's biggest Q3 2020 reduction was Pfizer, cutting an estimated $41M.
- Squarepoint fully exited Biogen in Q3 2020, selling an estimated $36.8M.
- Squarepoint's ten largest holdings make up 11% of its $7.42B portfolio in Q3 2020.
- Squarepoint opened 854 new positions and closed 600 in Q3 2020.
- Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.42B.
Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.